Fernando Fervenza

34PUBLICATIONS

50CO-AUTHORS

Cardiovascular medicine and haematology not elsewhere classifiedMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)PharmacogenomicsImmunogenetics (incl. genetic immunology)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (34)

Sort by Publication Date:

|Jul 08, 2026

Long-term eculizumab treatment failure in C3 glomerulonephritis: two case reports.

|Jun 05, 2026

Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy.

|Apr 08, 2026

A case of adrenal insufficiency after initiation of targeted-release budesonide formulation (Nefecon) in a patient with IgA nephropathy.

Trisha D Laxamana, Fernando C Fervenza, Richard J Glassock

|Feb 19, 2026

Finerenone with empagliflozin in CKD with diabetes (CONFIDENCE): only a blood pressure effect? Likely!

Maria J Soler, Paola Romagnani, Fernando C Fervenza

|Feb 18, 2026

Microscopic hematuria in IgA nephropathy: a biomarker of disease activity.

Jürgen Floege, Fernando C Fervenza, Rosanna Coppo

|Dec 03, 2025

Pegcetacoplan for Treatment of C3 Glomerulopathy and Immune-Complex MPGN.

Ladan Zand, Fernando C Fervenza

Pageof 6

Frequent Collaborators

13 joint publications

Sanjeev Sethi

Maria Soler

Marta Casal Moura

Kenneth J Warrington

Fernando Caravaca-Fontán

Alvise Berti

Ulrich Specks

Jack Wetzels

Cynthia S Crowson

Fan Fan Hou

Frequent Collaborators

13 joint publications

Sanjeev Sethi

4 joint publications

Maria Soler

3 joint publications

Marta Casal Moura

3 joint publications

Kenneth J Warrington